Icahn

Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016.David A. Grogan | CNBCCarl Icahn on Thursday expressed his support for Illumina's new CEO Jacob Thaysen – a relief for the company as it tries to rebound from a bitter…

The world's wealthiest 500 individuals experienced a staggering increase of $852 billion in their combined fortunes in the first half of 2023, averaging a remarkable $14 million per day for each member, according to data compiled by…

Rafael Henrique | Lightrocket | Getty ImagesActivist investor Carl Icahn on Thursday won enough support from Illumina shareholders to install one of his three nominees to the biotech company's board of directors. Shareholders also ousted…

Renowned billionaire investor Carl Icahn finds himself in an unexpected position after US short-seller Hindenburg Research targeted his investment vehicle, Icahn Enterprises LP, earlier this month. However, the 87-year-old Icahn, known as…

Billionaire investor Carl Icahn came under pressure again on Thursday as short seller Hindenburg Researchbegan shorting bonds in Icahn Enterprises LP (IEP) and said Icahn's firm has failed to address every key issue it had…

NEW DELHI: Corporate activist Carl Icahn is the latest target of US-based short-seller Hindenburg Research, with its bombshell revelations wiping out nearly one-fifth of his empire's value.Icahn’s vast fortunes tumbled more than $10 billion…

Over nearly a half-century, Carl Icahn has shaken up Wall Street as a corporate raider and activist shareholder, making corporate titans bow down to his demands and change their business strategies.But on Tuesday, his publicly traded…

Last Updated: May 03, 2023, 02:05 ISTFamed activist investor Carl Icahn. (Image: Hindenberg Research /Twitter)Hindenberg's report is the latest in a series of detailed investigations that have taken on some of the biggest names in businessA…

Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016.David A. Grogan | CNBCCarl Icahn on Friday called Illumina's first-quarter results "very disappointing" and slammed the DNA sequencing company's new plans to cut costs. …

Illumina CEO Francis deSouza on Wednesday touted the company's controversial acquisition of Grail after revenue from the cancer test developer doubled in the last year. The Grail deal is the focus of a heated proxy fight between Illumina…